Niranjan Y. Sardesai

2014

In 2014, Niranjan Y. Sardesai earned a total compensation of $1.2M as Chief Operating Officer at Inovio Pharmaceuticals, a 137% increase compared to previous year.

Compensation breakdown

Bonus$137,901
Option Awards$659,875
Salary$348,940
Other$11,325
Total$1,158,041

Sardesai received $659.9K in option awards, accounting for 57% of the total pay in 2014.

Sardesai also received $137.9K in bonus, $348.9K in salary and $11.3K in other compensation.

Rankings

In 2014, Niranjan Y. Sardesai's compensation ranked 6,942nd out of 13,032 executives tracked by ExecPay. In other words, Sardesai earned more than 46.7% of executives.

ClassificationRankingPercentile
All
6,942
out of 13,032
47th
Division
Manufacturing
2,546
out of 4,966
49th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
317
out of 736
57th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
171
out of 446
62nd
Industry
Surgical and Medical Instruments and Apparatus
96
out of 275
65th
Source: SEC filing on March 29, 2017.

Sardesai's colleagues

We found three more compensation records of executives who worked with Niranjan Y. Sardesai at Inovio Pharmaceuticals in 2014.

2014

J Kim

Inovio Pharmaceuticals

Chief Executive Officer

2014

Mark Bagarazzi

Inovio Pharmaceuticals

Chief Medical Officer

2014

Peter Kies

Inovio Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like